Current Research of Other UHN Researchers. UHN represents and warrants that, to the best of UHN’s knowledge as on the Effective Date, no UHN staff member, researcher or employee (excluding the Principal Investigators and those UHN employees, personnel, staff and students under their direct supervision) has developed, and/or are developing, as of the Reference Date and continuing to the Effective Date, any technology or Intellectual Property similar to the Licensed Technology specifically encompassing prognostic mRNA expression-based signatures to be used in the clinical management of lung cancers.
Appears in 3 contracts
Samples: Sponsored Research Agreement (Med BioGene Inc.), Sponsored Research Agreement (Med BioGene Inc.), Sponsored Research Agreement (Med BioGene Inc.)
Current Research of Other UHN Researchers. UHN represents and warrants that, to the best of UHN’s knowledge as on the Effective Date, no UHN staff member, researcher or employee (excluding the Principal Investigators and those UHN employees, personnel, staff and students under their direct supervision) has developed, and/or are developing, as of the Reference Date and continuing to the Effective Date, any technology or Intellectual Property similar to the Additional Licensed Technology specifically encompassing prognostic mRNA expression-based signatures to be used in the clinical management of lung cancers.
Appears in 3 contracts
Samples: Additional Sponsored Research Agreement (Med BioGene Inc.), Additional Sponsored Research Agreement (Med BioGene Inc.), Additional Sponsored Research Agreement (Med BioGene Inc.)